ClinicalTrials.Veeva

Menu

OM and Trauma Study (OMTP)

I

Institute of OM Foundation

Status and phase

Completed
Early Phase 1

Conditions

PTSD

Treatments

Behavioral: Orgasmic Meditation

Study type

Interventional

Funder types

Industry

Identifiers

NCT05577377
Pro00061665

Details and patient eligibility

About

The primary purpose of this study is to use an unblinded, uncontrolled, 1-month interventional single group pilot study, to assess the possibility of Orgasmic Meditation practice being used as a possible intervention for PTSD. The secondary purpose of this study is to examine if OM is associated with a decrease in the symptoms and self-assessed experiences associated with trauma.

The OM Trauma Protocol (OMTP) is designed to systematize the application of Orgasmic Meditation (OM) for individuals seeking relief from a wide variety of problems and/or help them in their pursuit of eudaimonia. The study protocol will evaluate whether OMing (the act of practicing OM) shows potential for being an effective intervention for people suffering from Post-Traumatic Stress Disorder (PTSD).

Enrollment

28 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults ≥18 years old
  • One or more participants of the pair having a diagnosis of PTSD for > 6 months
  • Relationship for > 6 months
  • Self or partner of female sex
  • Massachusetts residents
  • Access and ability to use internet and a video platform called Zoom
  • No history of doing the practice of OM

Exclusion criteria

  • Ongoing or active use of illicit drugs at the time of the study
  • Self-identify as pregnant
  • Inability to speak English
  • Recent hospitalization < 12 months
  • Suicidal ideation < 12 months
  • Self-harm < 12 months

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

28 participants in 1 patient group

OM intervention
Experimental group
Treatment:
Behavioral: Orgasmic Meditation

Trial contacts and locations

1

Loading...

Central trial contact

Rachel Pelletier, MS; Caroline Griggs, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems